Wealth Enhancement Advisory Services »

Apyx Medical Corporation shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Apyx Medical Corporation (APYX) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Apyx Medical Corporation

Tip: Access up to 7 years of quarterly data

All positions including Apyx Medical Corporation held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apyx Medical Corporation by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $215k 158k 1.36
2023-12-31 $414k 158k 2.62
2023-09-30 $507k 158k 3.20

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Moment (IMTM)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Alps Etf Tr Smith Core Plus (SMTH)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
American Centy Etf Tr Us Large Cap Vlu (AVLV)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Apyx Medical Corporation

Royce & Associates
AIGH Capital Management
Vanguard Group
Taylor Frigon Capital Management
Silverberg Bernstein Capital Management
Horizon Kinetics Asset Management
Worth Venture Partners
Commonwealth Equity Services
Dimensional Fund Advisors
Greenwood Capital Associates
Millennium Management
Perkins Capital Management
Wealth Enhancement Advisory Services
Squarepoint Ops
Raymond James Financial Services Advisors

View all funds holding Apyx Medical Corporation